Regulatory submission for the treatment of anaemia of chronic kidney disease based on the ASCEND phase III clinical trial programme, consisting of five trials that all met their primary efficacy and safety endpoints in non-dialysis and dialysis…Original Article
US Food and Drug Administration Accepts New Drug Application for Daprodustat
